MODL-03. Establishment of intraventricular Shh inhibition as a therapeutic option for young patients with medulloblastoma

The prognosis of pediatric medulloblastoma is still dissatisfying today and tumor survivors often suffer from severe treatment-related morbidities. This poses an urgent need for more efficient therapies. Shh medulloblastoma is characterized by mutations in the Sonic Hedgehog (Shh) pathway, providing...

Descripción completa

Detalles Bibliográficos
Autores principales: Kresbach, Catena, Schoof, Melanie, Holst, Lea, Leven, Tara, Yorgan, Timur, Wrzeszcz, Antonina, Rutkowski, Stefan, Schüller, Ulrich
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Preclinical Models/Experimental Therapy/Drug Discovery
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9164841/
http://dx.doi.org/10.1093/neuonc/noac079.626

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9164841/
http://dx.doi.org/10.1093/neuonc/noac079.626

Ejemplares similares